A EU partnership with an up front payment will be the fastest way to large profits for SSH , this surly must be going through Dave Rosa's mind , it is larger market than the US at 3.5 million sufferers , this will allow funds to progress the game changing CP2 to replace CP1 , a staged payment say $50 million up front and the balance $250 million subject to FDA approval , that will Re Rate SSH to $50 imediatly , give plenty cash to start new trials for angina and hypertension , this is an exciting time for SSH , Dave must be thinking very seriously on this option .
SHC Price at posting:
2.5¢ Sentiment: Buy Disclosure: Held